Literature DB >> 14681898

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.

Elsa Diguet, Richard Rouland, François Tison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14681898     DOI： 10.1002/ana.10818

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  5 in total

1.  Lack of minocycline efficiency in genetic models of Huntington's disease.

Authors:  Stéphane Mievis; Marc Levivier; David Communi; Gilbert Vassart; Jacques Brotchi; Catherine Ledent; David Blum
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.

Authors:  Xin Wang; Shan Zhu; Zhijuan Pei; Martin Drozda; Irina G Stavrovskaya; Steven J Del Signore; Kerry Cormier; Ethan M Shimony; Hongyan Wang; Robert J Ferrante; Bruce S Kristal; Robert M Friedlander
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

Review 3.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

4.  Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.

Authors:  Jin Wang; Silvia Gines; Marcy E MacDonald; James F Gusella
Journal:  BMC Neurosci       Date:  2005-01-13       Impact factor: 3.288

5.  Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.

Authors:  Carmela Giampà; Alessandra Alvino; Marta Magatti; Antonietta R Silini; Antonella Cardinale; Emanuela Paldino; Francesca R Fusco; Ornella Parolini
Journal:  J Cell Mol Med       Date:  2018-12-25       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.